戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 (7)(DMSA)(4), where DMSA represents meso-2,3-dimercaptosuccinic acid.
2                              (99m)Tc-labeled dimercaptosuccinic acid ((99m)Tc-DMSA) accumulates in th
3                Serial technetium-99m-labeled dimercaptosuccinic acid ((99m)Tc-DMSA) renal scintigraph
4 renal parenchymal disease on (99m)Technetium-dimercaptosuccinic acid ((99m)Tc-DMSA) scintigraphy.
5               These oral chelators, meso-2,3-dimercaptosuccinic acid and sodium 2,3-dimercapto-1-prop
6 cated in organic mercury exposures, meso-2,3-dimercaptosuccinic acid and sodium 2,3-dimercapto-1-prop
7                                              Dimercaptosuccinic acid-coated SPIONs are internalized a
8 exposed animals with the chelating agent 2,3-dimercaptosuccinic acid completely reversed the effect o
9                         The As(III) chelator dimercaptosuccinic acid did not block the transfer from
10      We also did a metastable 99mTc-labelled dimercaptosuccinic acid (DMSA) assay and contrast cystog
11 immersion into aqueous solutions of meso-2,3-dimercaptosuccinic acid (DMSA) at increasing concentrati
12 to-1-propanesulfonic acid (DMPS) or meso-2,3-dimercaptosuccinic acid (DMSA) caused a significant redu
13            Renal cortical imaging with 99mTc-dimercaptosuccinic acid (DMSA) has become the imaging te
14 he newborn babies soon after delivery, and a dimercaptosuccinic acid (DMSA) radioisotope scan at 3 mo
15 toacetyltriglycine (MAG3) renograms, (99m)Tc-dimercaptosuccinic acid (DMSA) renal cortical scans, (99
16                           Quantitative 99mTc-dimercaptosuccinic acid (DMSA) renal uptake was studied
17 ictive factor for areas of lack of uptake on dimercaptosuccinic acid (DMSA) scans (P < 0.01).
18 eiving kidney transplants had early and late dimercaptosuccinic acid (DMSA) scans to detect acquired
19  year later, ultrasonography, technetium 99m-dimercaptosuccinic acid (DMSA) scintigraphy, contrast ma
20 enal length measurements obtained with 99mTc-dimercaptosuccinic acid (DMSA) SPECT.
21 ciations between blood lead, tibia lead, and dimercaptosuccinic acid (DMSA)-chelatable lead and measu
22 cificity for APN were compared with those of dimercaptosuccinic acid (DMSA).
23 ully addressed by complexation with meso-2,3-dimercaptosuccinic acid (DMSA).
24  treatment with the oral chelating agent 2,3-dimercaptosuccinic acid (DMSA, succimer).
25 ; renal scanning with technetium-99m-labeled dimercaptosuccinic acid has also been endorsed by other
26                   A new drug, DMSA (meso 2,3-dimercaptosuccinic acid) has been approved for oral chel
27  of photopenia plus contour change on a late dimercaptosuccinic acid renal scan (obtained at study ex
28 rences (SFD) were quantified with technetium-dimercaptosuccinic acid renography.
29                                              Dimercaptosuccinic acid scans provide important informat
30 ify patients at risk for kidney damage, with dimercaptosuccinic acid scintigraphy as the reference me
31  phantoms have been used to simulate (99m)Tc-dimercaptosuccinic acid SPECT images.
32 thiol-based compounds dimercaptopropanol and dimercaptosuccinic acid suppressed toxicity in both HD c
33 luster, Ag(4)Ni(2)(DMSA)(4) (DMSA = meso-2,3-dimercaptosuccinic acid) was synthesized and characteriz

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。